IVUS-OCT Market

Key data points: Market size in 2027 = $46.2 million and 2035 = $191.2 million, growth forecast = 19.4% annually for the next 8 years. Scroll below to get more insights. This market report covers trends, opportunities and forecasts in IVUS-OCT market to 2035 by type (36 mm/s retraction speed, 25 mm/s retraction speed, 10 mm/s retraction speed, and others), application (hospital, ambulatory surgery center, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World) IVUS-OCT Market The future of the global ivus-oct market looks promising with opportunities in the hospital and ambulatory surgery center markets. The global ivus-oct market is expected to reach an estimated $191.2 million by 2035 from $46.2 million in 2027 with a CAGR of 19.4% from 2027 to 2035. The major drivers for this market are the increasing prevalence of cardiovascular diseases, the growing healthcare infrastructure in emerging market, and the rising investment in advanced medical imaging technology. • Lucintel forecasts that, within the type category, 36 mm/s retraction speed is expected to witness the highest growth over the forecast period due to faster image acquisition is enabled by higher retraction speeds. • Within the application category, hospital is expected to witness higher growth over the forecast period due to intravascular imaging is becoming more common in hospital cardiac procedures. • In terms of regions, APAC is expected to witness the highest growth over the forecast period due to more cases of cardiovascular disease are leading to more cardiac catheterization procedures. Gain valuable insights for your business decisions with our comprehensive 150+ page report. Sample figures with some insights are shown below. Emerging Trends in IVUS-OCT Market According to our report, between 2025 and 2027, the ivus-oct market will shift from specialty imaging to integrated in-vascular resolution. Separately, there is pressure on the healthcare sector to adopt technology which models anatomy and tissue, and pays only for services which demonstrate improvement in patient outcomes. While there are some new technologies available in this space, the main concern for the markets we cover is whether the technology improves healthcare worker’s productivity. • New Integrated Imaging Systems: More integrated systems will become available in the market from 2025 which will combine IVUS and OCT in the same modality. While OCT provides a better resolution than IVUS, IVUS is able to depict structures over a greater distance. However, both have limitations and each plays a complementary role in assessing coronary artery stenoses. This integration will allow the catheterization lab team to assess the whole extent of the lesion being evaluated, and possibly reduce the need for a subsequent modality. • New Artificial Intelligence and Image Processing Systems: There has been a focus by industry and academia in developing and commercializing image processing and artificial intelligence systems which assist clinicians and reduce the time required to interpret images. Some of these systems have been developed to detect and distinguish stent under expansion and dissection, and to identify and characterize coronary artery calcifications. Within the next five years, the market will be competitively dominated by systems which demonstrate the greatest improvement in productivity and consistency of the healthcare worker. • Evidence-led Adoption: In 2025, leading interventional cardiology meetings presented data showing the use of IVUS to better optimize stent implantation. As a result, the use of IVUS has been increasing for complex PCI. Traditionally, this type of PCI has only been performed at specialized centres. With growing evidence of the benefits of this technology, payers will approve the purchase of this system at more hospitals and health systems. • Automation and Connectivity: In 2026, it is anticipated that imaging systems will be integrated with other systems, such as cardiac output systems and structural reporting systems. Further, it is anticipated that systems will be programmed to perform automatic pull-backs to measure certain structures. • Regional Supply Diversification: 2025 procurement, or supply chain, personnel at hospitals and health systems began to evaluate alternate sources of supply for interventional cardiology products, as well as consider the establishment of a local inventory of these products. The establishment of local and regional supply and manufacturing partnerships should facilitate the establishment of local and regional inventories of interventional cardiology products in the near-term. From 2025-2027, the primary considerations for the purchase of IVUS systems by hospitals and health systems will be the systems' ability to positively impact clinical and economic outcomes of PCI and the evidence available to payers to support the purchase of these systems. While integrated systems will find a greater role in PCI, stand-alone systems will have a role in more established labour and cardiac catheterization labs. Recent Developments in the IVUS-OCT Market Recruitment of new employees in the IVUS market is expected between 2025 and 2027 with growing integration of IVUS in coronary procedures. Lucintel’s report mentions recent advancements in AI, interpretation of imaging findings, and evidence of reimbursement, as well as growing adoption by hospitals. • Advances in Imaging Software: In 2025, Abbott’s IVUS software, Ultreon, gained Regulatory Clearance to automate calcium scoring and stent Plaque assessment in additional European countries. The software automates some functions of IVUS imaging and is expected to reduce the time and personnel required for IVUS imaging. • Integration of IVUS with Other Modalities: In 2025, Philips released its system integrating IVUS and OCT for a range of vascular procedures. Hybrid systems integrate multiple imaging modalities in a single platform, and are expected to facilitate and enhance the interpretation and characterization of vascular lesions. • Software Partnerships: In 2025, several vendors and Medis signed strategic alliances to embed imaging and analysis software for Invasive Coronary and IVUS procedures. • Clinical Evidence Expansion: Claims data will drive the next wave of PCI guideline development and reimbursement. Large clinical data sets will likely inform practice, influence product coverage, and shape capital allocation. The next few years will likely witness a shift in new data sets driving reimbursement, coverage, and capital decisions similar to that created by the completion of the ISCHEMIA and RIAMI/Academy trials and relevant research. • Hospital Capital Investment: Investment in advanced cardiac imaging equipment is expected to increase in the near-term. While the volume of cardiac interventional procedures is expected to remain fairly flat, the modernization of cardiac and imaging laboratories will likely expand in the larger, higher volume cardiac centres. The market is shifts from high-end imaging equipment to adjacent products and services. Vendors that integrate the full range of products from catheter tip to system will gain the most market share and value. As such, we anticipate price pressure will continue on imaging equipment as health systems aim to reduce the total cost of owning and using a particular system. In the near-term, the debate around the role of IVUS and OCT will be inform the practice of interventional cardiology. Strategic Growth Opportunities in the IVUS-OCT Market Between 2024 and 2026, expected market trends show less focus on the sale of images and more focus on coronary decision support. This especially pertains to the performance of complex interventions in the cath lab. The Lucintel perspective shows that the market will be defined by customer workflows, software, and market segments. • Complex PCI: Hybrid imaging can improve the assessment of coronary lesions and support stent placement. Use of imaging in PCI has been increasing. A multicenter study presented in January 2025 described use in over 1000 cases. Imaging will play an even greater role in defining and facilitating interventional coronary procedures. • Comprehensive Imaging Systems: Sponsoring institutions will favor integrated systems. At the May 2025 meeting, manufacturers of intravascular systems showcased integrated systems. • Outpatient Cardiac Centres: Outpatient cardiac centres will be an emerging market. As of June 2025, the U.S. had over 6000 ambulatory surgery centres. • AI Enabled Interpretation: Using artificial intelligence (AI) to assist in clinical image assessment and analysis will create a new source of revenue. Claims made during October 2025 indicate that select assessments were automated and completed in less than 1 minute. It is expected that decision-making subscriptions will be among the first automated imaging assessments purchased by laboratories. • Emerging Market Expansion: Private cardiac care networks in the Middle East, Latin America, and Asia are under-developed. In February 2026, it was estimated that more than 5,000 cath-labs were installed in India. The formation of a similar market in the Middle East and Latin America will be facilitated by local training and the availability of less-expensive consumables and services. The market for IVUS and OCT will shift to integrating diagnoses and determining the best treatment. By 2030, there will be ample evidence supporting the clinical utility of these technologies in various specialties. Reimbursement will be based on the evidence and utility in various care settings. The evidence will influence the duration and magnitude of the shift to integrating these technologies into clinical practice. IVUS-OCT Market Drivers and Challenges Improving technology and varying clinical, economic and legal circumstances affect ivus-oct market conditions. More cardiovascular procedures and investment by hospitals and healthcare facilities as well as advances in medical technology and devices create opportunities. There are, however, obstacles to market penetration such as pricing, reimbursement and acceptance, and the level of training staff to use the devices. The factors responsible for driving this market include: • Increase in Cardiovascular Diseases: IVUS-OCT devices enable imaging with depth and resolution for diagnosis and treatment of coronary diseases and other cardiovascular conditions. It is estimated that cardiovascular diseases caused about 20.5 million deaths in 2025 and the figure will increase in the near future. Factors contributing to increased cardiovascular diseases and conditions include aging and larger population as well as unhealthy life styles. These will increase the demand for diagnostics and treatment for cardiovascular conditions in both the developed and the developing countries. • Improvements in Technology: Advances in catheter design and the automation of measurement and pullback as well as the integration of artificial intelligence in vascular intervention are improving the field. In 2025, some imaging platforms allowed pullback speeds of 40 millimeters per second, bringing procedure times down even further. Rapid pullback speeds will allow physicians to perform more complex interventions and integrate other robotic and computer assisted devices. • New Products: Manufacturers are also enhancing their products to include small, integrated consoles; combined imaging catheters; and software to automate lesion analysis and integrate other interventional imaging and planning functions. In 2025, the majority of intravascular imaging catheters had the capability to automatically analyse stent post-deployment. Over the next few years, similar advances in other products will allow intervention in previously unreachable areas. • Shifting Standards: As regulatory standards shift in the field of interventional cardiology, more advanced intravascular imaging devices will become more common. Given the value that recent clinical practice guidelines place on intravascular imaging, there is a strong potential for growth of the market in the coming years. However, medical device manufacturers will have to balance the needs of the healthcare market with strong cybersecurity and other regulatory compliances. • Infrastructure Investment: Investments in various types of cardiac catheterization facilities, as well as other related hybrid operating and digital imaging systems, are on the rise in the medical industry. As part of various public/private initiatives aimed at improving accessibility and timeliness of cardiac care, the volume of catheterization services offered by the health care system is anticipated to increase in the next few years. There will also be improvement in the infrastructure of both public and private health care facilities, including specialty cardiac care centres. This is expected to increase the availability of sophisticated cardiac imaging systems and related professional services in various geographic locations. The challenges facing this market include: • Expensive Equipment: The overall cost of owning and operating a cardiac catheterization system remains high because of the cost of specialized imaging catheters, the maintenance and upgrade contracts, and staff training. Some imaging catheter systems require more than one catheter for certain procedures. Disposable, imaging catheters used in several procedures add to the cost of the procedure. Leasing or rental agreements for imaging catheterization systems are expected to encourage market penetration, especially in smaller health care facilities. • Variability of Insurance Reimbursement: The uncertainty of adequate financial return for cardiac procedures limited the interest of private investors in developing the infrastructure for cardiac catheterization systems. It is expected that in the next few years, health care payers will become more interested in procedures that ultimately lower the cost of the health care system. • Training and Integration: This technology combines multiple aspects of image acquisition, analysis and interpretation, and requires skill in manipulating catheters to properly perform a procedure. In 2025, many institutions were able to integrate this technology with their existing systems. During the next several years, lack of skilled staff, inconsistency in integration with other systems, and disruption of workflow will slow the market growth. Sponsored by continued advances in technology, and focused on development of interpretative and planning automated systems, these barriers may be reduced. The market is poised to grow with advancing cardiovascular disease, more complex interventional procedures and increased focus on personalized medicine. Improvements in technology and the formation of strong partnerships between medical device and services companies to offer integrated solutions will improve market growth. Bottlenecks in the markets, especially in small and developing countries, will be influenced by company's ability to demonstrate the economic and clinical benefits of its products. Leading companies will be able to integrate advanced medical imaging and related products to provide end to end solutions in a cost optimized manner while addressing business and regulatory issues. List of IVUS-OCT Market Companies Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. Through these strategies ivus-oct market companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the ivus-oct market companies profiled in this report include- • Terumo • Conavi Medical • Grand Pharmaceutical • Horimed Care • Panovision Medical IVUS-OCT Market by Segment The study includes a forecast for the global ivus-oct market by type, application, and region. IVUS-OCT Market by Type [Value ($M) from 2019 to 2035]: • 36 mm/s Retraction Speed • 25 mm/s Retraction Speed • 10 mm/s Retraction Speed • Others IVUS-OCT Market by Application [Value ($M) from 2019 to 2035]: • Hospital • Ambulatory Surgery Center • Others IVUS-OCT Market by Region [Value ($M) from 2019 to 2035]: • North America • Europe • Asia Pacific • The Rest of the World Country Wise Outlook for the IVUS-OCT Market The market for IVUS-OCT is moving toward integrated products and services that include intravascular imaging and other software-based interventional procedures. Most manufacturers plan to launch their products between 2025 and 2027, with products and services that are integrated across the margins and offerings of artificial intelligence and catheter platforms. According to Lucintel’s latest report, other manufacturers and the pace of regulatory approvals will dictate the market. • United States: The market is currently led by Abbott and Boston Scientific. Abbott, in 2024, reported revenues of 44.3 billion dollars from its cardiovascular business. Both companies are focused on developing products and services to enable integrated imaging and procedures for interventional cardiology within the cath-lab. • China: The domestic market is also growing as the Chinese government provides more incentives for local production of cardiovascular devices. The China medical device market grew to over 1 trillion RMB in 2023. Similar trends are expected for IVUS-OCT systems in the China market. • Germany: Siemens Healthineers invested in integration of cardiovascular procedures and imaging. German research institutions and hospitals carried on with the clinical research in the field of ultrasound and catheter-based interventions. Siemens announced a revenue of 22.4 billion euros in fiscal 2024. German engineering and research will help establish Siemens’ business in Europe. • India: India’s public policy initiatives and the 2024-25 Union budget facilitated the local assembly of medical devices. The local market for medical devices was worth 11 billion dollars in 2024. Further, promotion of local production of devices and lighter rules for the industry will help reduce the price of medical devices and improve access. • Japan: Similarly, the public policy of Japan facilitated the growth of the medical devices industry. Reform of the Japanese regulatory framework and improvement in reimbursement policies helped embrace invasive catheter based diagnostic and therapeutic devices. Terumo reported a revenue of 1 trillion yen in fiscal 2024. Continuous interest of the Japanese government and industry in high tech medical devices and related services will enhance the regional supply and demand. Features of the Global IVUS-OCT Market Market Size Estimates: ivus-oct market size estimation in terms of value ($B). Trend and Forecast Analysis: Market trends (2019 to 2026) and forecast (2027 to 2035) by various segments and regions. Segmentation Analysis: ivus-oct market size by type, application, and region in terms of value ($B). Regional Analysis: ivus-oct market breakdown by North America, Europe, Asia Pacific, and Rest of the World. Growth Opportunities: Analysis of growth opportunities in different type, application, and regions for the ivus-oct market. Strategic Analysis: This includes M&A, new product development, and competitive landscape of the ivus-oct market. Analysis of competitive intensity of the industry based on Porter’s Five Forces model. If you are looking to expand your business in this or adjacent markets, then contact us. We have done hundreds of strategic consulting projects in market entry, opportunity screening, due diligence, supply chain analysis, M & A, and more. This report answers following 11 key questions: Q.1. What are some of the most promising, high-growth opportunities for the ivus-oct market by type (36 mm/s retraction speed, 25 mm/s retraction speed, 10 mm/s retraction speed, and others), application (hospital, ambulatory surgery center, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)? Q.2. Which segments will grow at a faster pace and why? Q.3. Which region will grow at a faster pace and why? Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market? Q.5. What are the business risks and competitive threats in this market? Q.6. What are the emerging trends in this market and the reasons behind them? Q.7. What are some of the changing demands of customers in the market? Q.8. What are the new developments in the market? Which companies are leading these developments? Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth? Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution? Q.11. What M&A activity has occurred in the last 8 years and what has its impact been on the industry?